Abstract

The review presents the results of clinical studies on the prognostic role of albuminuria A2 (microalbuminuria), mild renal dysfunction (estimated glomerular filtration rate — 60–74 ml/min/1,73 m 2), biomarkers of proximal tubular damage in hypertensive patients. Moreover, we discuss the data on the nephroprotective effects antihypertensive drugs, including calcium channel antagonist 3rd generation lercanidipine and β-blocker 3rd generation carvedilol.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.